SAM
ELDN icon

Senzar Asset Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Senzar Asset Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,154
Closed -$2.82M – 41
2016
Q2 		$2.82M Sell
3,154
-779
-20% -$859K 0.61% 37
2016
Q1 		$3.57M Buy
+3,933
New +$3.86M 0.71% 29

Other funds holding ELDN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Senzar Asset Management's ELDN Position: Q3 2016 in Review

Senzar Asset Management sold out of Eledon Pharmaceuticals (ELDN) in Q3 2016, closing a stake of 3,154 shares — an estimated $2.82M sold.

Senzar Asset Management first reported a position in ELDN in Q1 2016 and held it in 2 quarters. The position peaked at $3.57M in Q1 2016. 44 funds tracked by Wall St. Rank hold ELDN as of Q3 2016.

  • Senzar Asset Management reported no remaining Eledon Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Senzar Asset Management sold 3,154 Eledon Pharmaceuticals shares in Q3 2016, an estimated $2.82M.
  • Senzar Asset Management first reported a position in Eledon Pharmaceuticals in Q1 2016 and held it in 2 quarters.
  • Senzar Asset Management's Eledon Pharmaceuticals position peaked at $3.57M in Q1 2016.
  • 44 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2016.

Based on Senzar Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.